Rational Choice of Mechanical and Bioprosthesis Valve_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

JIANGWen , ZHOUCheng-bin ,  GUOHui-ming

Department of Cardiac Surgery, Guangdong Academy of Medical Sciences, Guangdong Provincial Cardiovascular Institute, Guangdong General Hospital, Guangzhou 510080, P. R. China;

Corresponding?author：

GUOHui-ming, Email: guohuiming@vip.tom.com

Keywords：

Prosthesis heart valve; Mechanical valve; Bioprosthesis valve; Aortic valve replacement; Mitral valve replacement

DOI：

10.7507/1007-4848.20150096

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Heart valve replacement is the major surgical treatment of severe valvular diseases. Due to the durability and reoperation-free, mechanical valves are widely used. Bioprosthesis valves became popular recently because of long service life and no demand for lifelong anticoagulation. However, how to choose the appropriate prosthetic heart valves, especially the application of bioprosthesis valves for patients at 55 to 65 years is still a major problem. This review focuses on more effective and scientific basis for rational choice of mechanical and bioprosthesis valve.

Citation： JIANGWen, ZHOUCheng-bin, GUOHui-ming. Rational Choice of Mechanical and Bioprosthesis Valve. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2015, 22(4): 361-365. doi: 10.7507/1007-4848.20150096 Copy

1.	Kallikazaros IE.Transcatheter aortic valve replacement:current status and future prospects.Hellenic J Cardiol, 2014, 55(4):349-350.
2.	Lincoln J, Garg V.Etiology of valvular heart disease.Circ J, 2014, 78(8):1801-1807.
3.	van den Hanenberg F, Mairuhu G, Kalisvaart CJ, et al.Aortic valve replacement and screening for frailty.Ned Tijdschr Geneeskd, 2014, 158:A7381.
4.	El-Mawardy M, Abdel-Wahab M, Richardt G.Transcatheter aortic valve implantation:technique, complications and perspectives.Expert Rev Cardiovasc Ther, 2014, 12(8):1005-1024.
5.	Brinkley DM, Gelfand EV.Valvular heart disease:classic teaching and emerging paradigms.Am J Med, 2013, 126(12):1035-1042.
6.	Hough A, Woods D.Antithrombotic therapy after transcatheter aortic valve replacement.JAMA, 2014, 311(12):1249-1250.
7.	Steger V, Bail DH, Graf D, et al.A practical approach for bridging anticoagulation after mechanical heart valve replacement.J Heart Valve Dis, 2008, 17(3):335-342.
8.	Gammie JS, Sheng S, Griffith BP, et al.Trends in mitral valve surgery in the united states:results from the society of thoracic surgeons adult cardiac surgery database.Ann Thorac Surg, 2009, 87(5):1431-1437.
9.	Cerillo AG, Berti S, Glauber M.Transjugular tricuspid valve-in-valve implantation:a safe and effective approach.Ann Thorac Surg, 2011, 92(2):777-778.
10.	Faerber G, Schleger S, Diab M, et al.Valve-in-valve transcatheter aortic valve implantation:the new playground for prosthesis-patient mismatch.J Interv Cardiol, 2014, 27(3):287-292.
11.	Stein PD, Alpert JS, Bussey HI, et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest, 2001, 119(1 Suppl):220S-227S.
12.	Gadey G, Reynolds MR.Cost-effectiveness considerations in transcatheter management of valvular heart disease.Can J Cardiol, 2014, 30(9):1058-1063.
13.	Jategaonkar SR, Scholtz W, Horstkotte D, et al.Transfemoral aortic valve-in-valve implantation with the corevalve evolut for small degenerated stented bioprosthesis.J Invasive Cardiol, 2014, 26(6):291-294.
14.	Alshehri HZ, Ismail M, Ibrahim MF.Obstructive bioprosthetic mitral valve thrombus:management options?Asian Cardiovasc Thorac Ann, 2014, 22(8):975-978.
15.	Kaneko T, Cohn LH, Aranki SF.Tissue valve is the preferred option for patients aged 60 and older.Circulation, 2013, 128(12):1365-1371.
16.	Suri RM, Schaff HV.Selection of aortic valve prostheses:contem-porary reappraisal of mechanical versus biologic valve substitutes.Circulation, 2013, 128(12):1372-1380.
17.	von Segesser LK, Gerosa G, Borger MA, et al.Prevention and management of potential adverse events during transapical aortic valve replacement.J Heart Valve Dis, 2013, 22(3):276-286.
18.	Meszaros K, Liniger S, Czerny M, et al.Mid-term results of aortic root replacement using a self-assembled biological composite graft.Interact Cardiovasc Thorac Surg, 2014, 19(4):584-589.
19.	Rubino AS, Santarpino G, De Praetere H, et al.Early and interme-diate outcome after aortic valve replacement with a suturelessbio-prosthesis:results of a multicenter study.J Thorac Cardiovasc Surg, 2014, 148(3):865-871.
20.	Weber A, Noureddine H, Englberger L, et al.Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.J Thorac Cardiovasc Surg, 2012, 144(5):1075-1083.
21.	Brown ML, Schaff HV, Lahr BD, et al.Aortic valve replacement in patients aged 50 to 70 years:improved outcome with mechanical versus biologic prostheses.J Thorac Cardiovasc Surg, 2008, 135(4):878-884.
22.	Kulik A, Bedard P, Lam BK, et al.Mechanical versus bioprosthetic valve replacement in middle-aged patients.Eur J Cardiothorac Surg, 2006, 30(3):485-491.
23.	Huang G, Rahimtoola SH.Prosthetic heart valve.Circulation, 2011, 123(22):2602-2605.
24.	Hammermeister K, Sethi GK, Henderson WG, et al.Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve:final report of the Veterans Affairs randomized trial.J Am Coll Cardiol, 2000, 36(4):1152-1158.
25.	van Geldorp MW, Eric JW, Kappetein AP, et al.Patient outcome after aortic valve replacement with a mechanical or biological prosthesis:weighing lifetime anticoagulant-related event risk against reoperation risk.J Thorac Cardiovasc Surg, 2009, 137(4):881-886.
26.	Carrel TP, Englberger L.Mechanical versus bioprosthetic mitral valve replacement in patients younger than 65 years.J Thorac Cardiovasc Surg, 2014, 147(3):853-854.
27.	Rahimtoola SH.Choice of prosthetic heart valve in adults an update.J Am Coll Cardiol, 2010, 55(22):2413-2426.
28.	Badhwar V, Ofenloch JC, Rovin JD, et al.Noninferiority of closely monitored mechanical valves to bioprostheses overshadowed by early mortality benefit in younger patients.Ann Thorac Surg, 2012, 93(3):748-753.
29.	Bach DS, Kon ND.Long-term clinical outcomes 15 years after aortic valve replacement with the Freestyle stentless aortic bioprosthesis.Ann Thorac Surg, 2014, 97(2):544-551.
30.	Biglioli P, Spampinato N, Cannata A, et al.Long-term outcomes of the Carpentier-Edwards pericardial valve prosthesis in the aortic position:effect of patient age.J Heart Valve Dis, 2004, 13(Suppl 1):S49-S51.
31.	Borger MA, Ivanov J, Armstrong S, et al.Twenty-year results of the HancockⅡbioprosthesis.J Heart Valve Dis, 2006, 15(1):49-56.
32.	Myken PS, Bech-Hansen O.A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis.J Thorac Cardiovasc Surg, 2009, 137(1):76-81.
33.	Banbury MK, Cosgrove DR, White JA, et al.Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis.Ann Thorac Surg, 2001, 72(3):753-757.
34.	Jaquiss RD.Bioprosthetic aortic valve replacement in the young:a cautionary tale.Circulation, 2014, 130(1):7-9.
35.	Dvir D, Webb JG, Bleiziffer S, et al.Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.JAMA, 2014, 312(2):162-170.
36.	Bonow RO, Carabello BA, Kanu C, et al.ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease):developed in collaboration with the Society of Cardiovascular Anesthesiologists:endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.Circulation, 2006, 114(5):e84-e231.
37.	李新民, 侯明曉, 汪曾煒, 等.老年瓣膜病患者心瓣膜置換術的臨床分析.中國胸心血管外科臨床雜志, 2011, 18(4):365-366.
38.	袁忠祥, 楊迪成.70歲以上瓣膜病患者心瓣膜置換術235例臨床分析.中國胸心血管外科臨床雜志, 2011, 18(1):72-74.
39.	Vahanian A, Alfieri O, Andreotti F, et al.Guidelines on the management of valvular heart disease (version 2012):the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).Eur J Cardiothorac Surg, 2012, 42(4):S1-S44.
40.	魏大闖, 黃煥雷, 肖學鈞, 等.左心瓣膜置換術后孤立性三尖瓣關閉不全的外科治療.中國胸心血管外科臨床雜志, 2014, 21(2):178-183.
41.	Rescigno G, Piva T, Mazzanti I, et al.Conventional surgery results in patients originally referred for transcatheter aorticvalve implanta-tion.J Cardiovasc Med (Hagerstown), 2015, 16(4):267-270.
42.	Alsara O, Alsarah A, Laird-Fick H.Advanced age and the clinical outcomes of transcatheter aortic valve implantation.J Geriatr Cardiol, 2014, 11(2):163-170.
43.	Kasel AM, Cassese S, Ischinger T, et al.A prospective, non-rando-mized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis.Am J Cardiovasc Dis, 2014, 4(2):87-99.
44.	Khan MS, Bawany FI, Dar MI, et al.Predictors of the size of prosthetic aortic valve and in-hospital mortality in aorticvalve replacement.Glob J Health Sci, 2014, 6(4):33877.
45.	Nakamura H, Yamaguchi H, Takagaki M, et al.Rigorous patient-prosthesis matching of Perimount Magna aortic bioprosthesis.Asian Cardiovasc Thorac Ann, 2015, 23(3):261-266.

1. Kallikazaros IE.Transcatheter aortic valve replacement:current status and future prospects.Hellenic J Cardiol, 2014, 55(4):349-350.
2. Lincoln J, Garg V.Etiology of valvular heart disease.Circ J, 2014, 78(8):1801-1807.
3. van den Hanenberg F, Mairuhu G, Kalisvaart CJ, et al.Aortic valve replacement and screening for frailty.Ned Tijdschr Geneeskd, 2014, 158:A7381.
4. El-Mawardy M, Abdel-Wahab M, Richardt G.Transcatheter aortic valve implantation:technique, complications and perspectives.Expert Rev Cardiovasc Ther, 2014, 12(8):1005-1024.
5. Brinkley DM, Gelfand EV.Valvular heart disease:classic teaching and emerging paradigms.Am J Med, 2013, 126(12):1035-1042.
6. Hough A, Woods D.Antithrombotic therapy after transcatheter aortic valve replacement.JAMA, 2014, 311(12):1249-1250.
7. Steger V, Bail DH, Graf D, et al.A practical approach for bridging anticoagulation after mechanical heart valve replacement.J Heart Valve Dis, 2008, 17(3):335-342.
8. Gammie JS, Sheng S, Griffith BP, et al.Trends in mitral valve surgery in the united states:results from the society of thoracic surgeons adult cardiac surgery database.Ann Thorac Surg, 2009, 87(5):1431-1437.
9. Cerillo AG, Berti S, Glauber M.Transjugular tricuspid valve-in-valve implantation:a safe and effective approach.Ann Thorac Surg, 2011, 92(2):777-778.
10. Faerber G, Schleger S, Diab M, et al.Valve-in-valve transcatheter aortic valve implantation:the new playground for prosthesis-patient mismatch.J Interv Cardiol, 2014, 27(3):287-292.
11. Stein PD, Alpert JS, Bussey HI, et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest, 2001, 119(1 Suppl):220S-227S.
12. Gadey G, Reynolds MR.Cost-effectiveness considerations in transcatheter management of valvular heart disease.Can J Cardiol, 2014, 30(9):1058-1063.
13. Jategaonkar SR, Scholtz W, Horstkotte D, et al.Transfemoral aortic valve-in-valve implantation with the corevalve evolut for small degenerated stented bioprosthesis.J Invasive Cardiol, 2014, 26(6):291-294.
14. Alshehri HZ, Ismail M, Ibrahim MF.Obstructive bioprosthetic mitral valve thrombus:management options?Asian Cardiovasc Thorac Ann, 2014, 22(8):975-978.
15. Kaneko T, Cohn LH, Aranki SF.Tissue valve is the preferred option for patients aged 60 and older.Circulation, 2013, 128(12):1365-1371.
16. Suri RM, Schaff HV.Selection of aortic valve prostheses:contem-porary reappraisal of mechanical versus biologic valve substitutes.Circulation, 2013, 128(12):1372-1380.
17. von Segesser LK, Gerosa G, Borger MA, et al.Prevention and management of potential adverse events during transapical aortic valve replacement.J Heart Valve Dis, 2013, 22(3):276-286.
18. Meszaros K, Liniger S, Czerny M, et al.Mid-term results of aortic root replacement using a self-assembled biological composite graft.Interact Cardiovasc Thorac Surg, 2014, 19(4):584-589.
19. Rubino AS, Santarpino G, De Praetere H, et al.Early and interme-diate outcome after aortic valve replacement with a suturelessbio-prosthesis:results of a multicenter study.J Thorac Cardiovasc Surg, 2014, 148(3):865-871.
20. Weber A, Noureddine H, Englberger L, et al.Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.J Thorac Cardiovasc Surg, 2012, 144(5):1075-1083.
21. Brown ML, Schaff HV, Lahr BD, et al.Aortic valve replacement in patients aged 50 to 70 years:improved outcome with mechanical versus biologic prostheses.J Thorac Cardiovasc Surg, 2008, 135(4):878-884.
22. Kulik A, Bedard P, Lam BK, et al.Mechanical versus bioprosthetic valve replacement in middle-aged patients.Eur J Cardiothorac Surg, 2006, 30(3):485-491.
23. Huang G, Rahimtoola SH.Prosthetic heart valve.Circulation, 2011, 123(22):2602-2605.
24. Hammermeister K, Sethi GK, Henderson WG, et al.Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve:final report of the Veterans Affairs randomized trial.J Am Coll Cardiol, 2000, 36(4):1152-1158.
25. van Geldorp MW, Eric JW, Kappetein AP, et al.Patient outcome after aortic valve replacement with a mechanical or biological prosthesis:weighing lifetime anticoagulant-related event risk against reoperation risk.J Thorac Cardiovasc Surg, 2009, 137(4):881-886.
26. Carrel TP, Englberger L.Mechanical versus bioprosthetic mitral valve replacement in patients younger than 65 years.J Thorac Cardiovasc Surg, 2014, 147(3):853-854.
27. Rahimtoola SH.Choice of prosthetic heart valve in adults an update.J Am Coll Cardiol, 2010, 55(22):2413-2426.
28. Badhwar V, Ofenloch JC, Rovin JD, et al.Noninferiority of closely monitored mechanical valves to bioprostheses overshadowed by early mortality benefit in younger patients.Ann Thorac Surg, 2012, 93(3):748-753.
29. Bach DS, Kon ND.Long-term clinical outcomes 15 years after aortic valve replacement with the Freestyle stentless aortic bioprosthesis.Ann Thorac Surg, 2014, 97(2):544-551.
30. Biglioli P, Spampinato N, Cannata A, et al.Long-term outcomes of the Carpentier-Edwards pericardial valve prosthesis in the aortic position:effect of patient age.J Heart Valve Dis, 2004, 13(Suppl 1):S49-S51.
31. Borger MA, Ivanov J, Armstrong S, et al.Twenty-year results of the HancockⅡbioprosthesis.J Heart Valve Dis, 2006, 15(1):49-56.
32. Myken PS, Bech-Hansen O.A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis.J Thorac Cardiovasc Surg, 2009, 137(1):76-81.
33. Banbury MK, Cosgrove DR, White JA, et al.Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis.Ann Thorac Surg, 2001, 72(3):753-757.
34. Jaquiss RD.Bioprosthetic aortic valve replacement in the young:a cautionary tale.Circulation, 2014, 130(1):7-9.
35. Dvir D, Webb JG, Bleiziffer S, et al.Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.JAMA, 2014, 312(2):162-170.
36. Bonow RO, Carabello BA, Kanu C, et al.ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease):developed in collaboration with the Society of Cardiovascular Anesthesiologists:endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.Circulation, 2006, 114(5):e84-e231.
37. 李新民, 侯明曉, 汪曾煒, 等.老年瓣膜病患者心瓣膜置換術的臨床分析.中國胸心血管外科臨床雜志, 2011, 18(4):365-366.
38. 袁忠祥, 楊迪成.70歲以上瓣膜病患者心瓣膜置換術235例臨床分析.中國胸心血管外科臨床雜志, 2011, 18(1):72-74.
39. Vahanian A, Alfieri O, Andreotti F, et al.Guidelines on the management of valvular heart disease (version 2012):the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).Eur J Cardiothorac Surg, 2012, 42(4):S1-S44.
40. 魏大闖, 黃煥雷, 肖學鈞, 等.左心瓣膜置換術后孤立性三尖瓣關閉不全的外科治療.中國胸心血管外科臨床雜志, 2014, 21(2):178-183.
41. Rescigno G, Piva T, Mazzanti I, et al.Conventional surgery results in patients originally referred for transcatheter aorticvalve implanta-tion.J Cardiovasc Med (Hagerstown), 2015, 16(4):267-270.
42. Alsara O, Alsarah A, Laird-Fick H.Advanced age and the clinical outcomes of transcatheter aortic valve implantation.J Geriatr Cardiol, 2014, 11(2):163-170.
43. Kasel AM, Cassese S, Ischinger T, et al.A prospective, non-rando-mized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis.Am J Cardiovasc Dis, 2014, 4(2):87-99.
44. Khan MS, Bawany FI, Dar MI, et al.Predictors of the size of prosthetic aortic valve and in-hospital mortality in aorticvalve replacement.Glob J Health Sci, 2014, 6(4):33877.
45. Nakamura H, Yamaguchi H, Takagaki M, et al.Rigorous patient-prosthesis matching of Perimount Magna aortic bioprosthesis.Asian Cardiovasc Thorac Ann, 2015, 23(3):261-266.

Previous Article
Evidence Based Imaging Strategies for Solitary Pulmonary Nodule
Next Article
Research Progress of Preoperative Predictors of New Onset Atrial Fibrillation after Coronary Artery Bypass Grafting

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Rational Choice of Mechanical and Bioprosthesis Valve

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content